Blauvelt, A., Langley, R. G., Peris, K., Silvestre, J. F., Katoh, N., Tauber, M., Pinter, A., Ameen, M., Gooderham, M., Øland, C. B., Tindberg, A.-M., Gjerum, L., & Reich, K. (2024). Continuous Tralokinumab Treatment over 4 Years in Adults with Moderate-to-Severe Atopic Dermatitis Provides Long-Term Disease Control. SKIN The Journal of Cutaneous Medicine, 8(2), s376. https://doi.org/10.25251/skin.8.supp.376